8 children with precocious puberty were treated with cyproterone acetate (CPA). During treatment there were no definite clinical signs of depressed adrenocortical function. The plasma cortisol concentrations were grossly depressed and the diurnal cortisol rhythm was abolished. Two months after disco
The effect of cyproterone acetate on the growth of children with central precocious puberty
β Scribed by R. Stanhope; K. -F. Huen; F. Buzi; M. A. Preece; D. B. Grant
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 369 KB
- Volume
- 146
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
We have examined the growth and skeletal maturation of 19 children (6 male, 13 female) with central precocious puberty. The aetiology in nine patients (5 male, 4 female) was secondary to a hypothalamic hamartoma. Six children (2 male, 4 female) received no treatment whereas 13 children (4 male, 9 female) were treated with cyproterone acetate in a mean dose of 68 mg/m 2 per day (range, 34-260) for a mean duration of 4.5 years (range, 0.8-7.9). There was no significant difference between height SDS for bone age at the beginning and end of observation in either treated or untreated groups. No significant relationship between the mean dose of cyproterone acetate used and change in height SDS for bone age could be determined. We conclude that cyproterone acetate has no beneficial effect on the growth prognosis of children with central precocious puberty.
π SIMILAR VOLUMES
## Abstract It has recently been reported that prednisone increases whereas dexamethasone and cortisone decrease insulin binding to monocytes, thus suggesting that different steroids may exert opposite effects on the insulin receptor, depending on their chemical structure. In order to gain further